Skip to main content
DOUBLE MEDICAL TECHNOLOGY INC. logo

DOUBLE MEDICAL TECHNOLOGY INC. — Investor Relations & Filings

Ticker · 002901 ISIN · CNE1000032W7 LEI · 836800DECKX5CGFNMD42 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 963 across all filing types
Latest filing 2023-04-28 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002901

About DOUBLE MEDICAL TECHNOLOGY INC.

https://www.double-medical.com

Double Medical Technology Inc. specializes in the development, manufacturing, and distribution of medical devices, with a primary focus on orthopedic solutions. The company's extensive product portfolio includes trauma fixation systems, spinal implants, joint prosthesis, and neurosurgical devices. Additionally, it provides specialized surgical instruments and advanced wound care products. Double Medical emphasizes research and innovation to deliver clinically effective solutions for complex musculoskeletal conditions. Its manufacturing processes adhere to international quality standards, ensuring the reliability of its implants and instruments used in hospitals and surgical centers worldwide. The company serves a global market, providing comprehensive support for orthopedic surgeons through its diverse range of reconstructive and regenerative medical technologies.

Recent filings

Filing Released Lang Actions
中信证券股份有限公司关于大博医疗科技股份有限公司2023年度继续使用暂时闲置的自有资金进行现金管理的核查意见
Regulatory Filings Classification · 95% confidence The document is a detailed verification opinion from CITIC Securities regarding the 2023 use of temporarily idle funds by Dabao Medical Technology Co., Ltd. for cash management. It includes descriptions of the purpose, scope, risk control measures, board and independent director approvals, and the sponsor's verification opinion. The document references regulatory rules and internal approvals but does not contain financial statements or quarterly/yearly financial results. It is a regulatory compliance and verification report related to the company's cash management activities rather than a financial report or earnings release. The document length is about 3,076 characters, which is relatively short but contains substantive content rather than just an announcement. It is not a certification letter or a simple announcement of a report. The content fits best under Regulatory Filings (RNS) as it is a regulatory compliance document verifying the company's cash management practices and approvals, without being a full financial report or earnings release.
2023-04-28 Chinese
2022年度监事会工作报告
Audit Report / Information Classification · 95% confidence The document is titled as the "2022年度监事会工作报告" which translates to "2022 Supervisory Board Work Report". It details the supervisory board's activities, oversight of company operations, financial audits, internal controls, and compliance with laws and regulations for the fiscal year 2022. It includes specific financial figures and audit opinions but is focused on the supervisory board's work rather than the full annual financial statements or comprehensive company performance. The document length is 2129 characters, which is relatively short and more consistent with a supervisory or audit-related report rather than a full Annual Report (10-K). It is not a simple announcement or certification but a substantive report on supervisory activities and audit opinions. This fits best with the category of Audit Report / Information (AR), which includes standalone audit reports and supervisory board reports on financial and operational oversight. FY 2022
2023-04-28 Chinese
关于开展2023年度外汇衍生品交易的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by a company regarding its plan to conduct foreign exchange derivative transactions in the fiscal year 2023. It includes details about the purpose, scope, risk analysis, risk control measures, and opinions from independent directors, the supervisory board, and the sponsoring institution. The document is relatively short (2188 characters) and does not contain any financial statements or substantive financial data. It is an announcement of a corporate action related to financing or capital management (foreign exchange derivatives trading) rather than a full financial report or regulatory filing. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2023-04-28 Chinese
年度募集资金使用鉴证报告
Regulatory Filings
2023-04-28 Chinese
中信证券股份有限公司关于大博医疗科技股份有限公司2022年度内部控制自我评价报告的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from CITIC Securities regarding the 2022 internal control self-evaluation report of Dabao Medical Technology Co., Ltd. It discusses the scope, standards, and conclusions of the internal control evaluation, including financial and non-financial control defects, governance structure, risk assessment, control activities, and internal supervision. The document is not the internal control report itself but a verification or audit opinion on that report. It is a standalone audit-related document focusing on internal control evaluation and compliance with regulatory requirements, without presenting full financial statements or annual report content. Therefore, it fits best under the category of Audit Report / Information (AR). FY 2022
2023-04-28 Chinese
中信证券股份有限公司关于大博医疗科技股份有限公司2022年度募集资金年度存放与使用情况的专项核查报告
Audit Report / Information Classification · 95% confidence The document is titled as a "专项核查报告" (special inspection report) regarding the annual deposit and use of raised funds for the year 2022 by Dabao Medical Technology Co., Ltd. It is prepared by CITIC Securities as the sponsor. The content details the amount of funds raised, their deposit, management, usage, and compliance with regulatory requirements. It includes tables of fund usage, bank accounts, cash management products, and audit opinions from an accounting firm. The document is focused on the verification and audit of the use of raised funds, not a full annual report or interim financial report. It is a specialized audit or verification report related to fundraising and fund usage compliance, which fits the definition of an Audit Report / Information (AR). The document length is about 5952 characters, which is sufficient for a detailed report rather than a brief announcement. There is no indication that this is a general regulatory filing or a report publication announcement. Therefore, the best classification is AR (Audit Report / Information). FY 2022
2023-04-28 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.